SCHEMBL6300185

SCHEMBL6300185

O=C1CCC(c2cccc(Cl)c2)c2cc(O)ccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 6/20 0.41
MAOA P21397 5/20 0.41
PRKCI P41743 1/20 0.40
MDM2 Q00987 2/20 0.40
LMNA P02545 2/20 0.39
HTT P42858 2/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
CYP19A1 P11511 1/20 0.39
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
KMT2A Q03164 1/20 0.38
GRM5 P41594 1/20 0.38
TSHR P16473 2/20 0.38
CYP2D6 P10635 1/20 0.37
ALOX15 P16050 1/20 0.37
NFKB1 P19838 1/20 0.37
THPO P40225 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6301379 0.85 ALDH1A1 (0.49) MAOBMAOAPRKCIKDM4EALDH1A1
SCHEMBL7749761 0.83 GAA (0.43) MDM2LMNAHTTKDM4EALDH1A1
SCHEMBL6300145 0.81 DDB1 (0.46) MAOBMAOALMNAHTTKDM4E
SCHEMBL8919310 0.79 CYP19A1 (0.46) MAOBMAOAKDM4ECYP19A1ALOX15
SCHEMBL11277278 0.72 HTR2C (0.41)
SCHEMBL7324722 0.70 VHL (0.41) MDM2CYP19A1SLC6A2SLC6A3TP53
SCHEMBL8920465 0.68 CYP19A1 (0.50) MAOBKDM4EALDH1A1CYP19A1SLC6A2
SCHEMBL2490001 0.67 RAB9A (0.46) LMNAHTTKDM4EALDH1A1NPSR1
SCHEMBL7736643 0.67 SLC6A2 (0.55) LMNASLC6A2SLC6A4SLC6A3KMT2A
SCHEMBL6261864 0.67 SLC6A2 (0.55) LMNASLC6A2SLC6A4SLC6A3KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6943183-B2 5-substituted tetralones as inhibitors of ras farnesyl transferase PFIZER INC (US) 2005-09-13 US disclosed
US-20040044057-A1 5- substituted tetralones as inhibitors of ras farnesyl trransferase WARNER-LAMBERT COMPANY 2004-03-04 US disclosed
EP-1276725-A2 5-SUBSTITUTED TETRALONES AS INHIBITORS OF RAS FARNESYL TRANSFERASE WARNER-LAMBERT COMPANY (US) 2003-01-22 EP disclosed
WO-2001079180-A2 5-SUBSTITUTED TETRALONES AS INHIBITORS OF RAS FARNESYL TRANSFERASE WARNER-LAMBERT COMPANY (US) 2001-10-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040044057-A1 5- substituted tetralones as inhibitors of ras farnesyl trransferase PTAR1, FNTA, GGPS1 MAOB 2947/4885MAOA 3197/4885PRKCI 1911/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.